SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-012643
Filing Date
2021-06-28
Accepted
2021-06-28 11:00:40
Documents
1
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6912
  Complete submission text file 0001567619-21-012643.txt   8594
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 333 EAST MAIN STREET SUITE 200 LOUISVILLE KY 40202
Business Address 333 EAST MAIN STREET SUITE 200 LOUISVILLE KY 40202 502-709-7544
Abuse Deterrent Pharma, LLC (Reporting) CIK: 0001782327 (see all company filings)

State of Incorp.: KY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 211050987